Found 0 matching trials
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies PHASE1 This is an open-label, safety study of a single ProHema-CB product administ...
Show More Learn More & Join Trial
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders NA To improve survival outcomes for patients with MDS and MPD with a nonmyeloa...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer PHASE2 RATIONALE: Giving chemotherapy and total body irradiation before a donor bo...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Allogeneic Transplant in HIV Patients (BMT CTN 0903) PHASE2 The rationale for this trial is to demonstrate the feasibility and safety o...
Show More Location
Mayo Clinic - Phoenix
Learn More & Join Trial
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer PHASE1 Men with progressive metastatic Castration-Resistant Prostate Cancer post f...
Show More Location
Johns Hopkins Hospital
Learn More & Join Trial
Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant N/A Allogeneic transplantation is used to treat many malignant and non-malignan...
Show More Location
Duke University Health System
Learn More & Join Trial
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets NA In the transplant community, there is debate regarding the most appropriate...
Show More Location
Duke University Medical Center
Learn More & Join Trial
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia PHASE3 RATIONALE: Giving chemotherapy, such as fludarabine phosphate, busulfan, an...
Show More Location
HealthOne Presbyterian St. Lukes Medical Center
Learn More & Join Trial
Plerixafor/G-CSF as Additional Agents for Conditioning Before HSCT in CGD Patients PHASE2 Treatment Study to assess of safety and efficiency of conditioning with Ple...
Show More Location
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies NA The purpose of this study is to determine disease-free survival, overall su...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial